Heartland Group (HGH) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
15 Jun, 2026Executive summary
Reported NPAT for FY2024 was $74.5 million, down 22.2% year-over-year, with underlying NPAT at $102.7 million, 4.9% below guidance, mainly due to elevated provisions and one-off items.
Receivables grew 6.4% to $7.2 billion, with strong expansion in reverse mortgages in NZ (up 20.2%) and Australia (up 19.7%).
Strategic milestones included the acquisition and integration of Challenger Bank (now Heartland Bank Australia), a $210 million equity raise, and a core banking system upgrade in New Zealand.
FY2024 results were impacted by deteriorating economic conditions in late FY2024, leading to increased provisions, especially in Asset Finance, Motor Finance, and Rural portfolios.
Financial highlights
Net interest income was $277.6 million, down 1.5% year-over-year, with reported NIM at 3.39% (down 58 bps) and underlying NIM at 3.64% (down 36 bps).
Operating expenses rose to $139.4 million, with underlying OPEX down $1.3 million but higher IT and personnel costs; CTI ratio was 48.0% (reported) and 41.9% (underlying).
Impairment expense nearly doubled to $46.4 million, with total provisioning up $22 million and underlying impairment expense ratio at 0.44%.
Final dividend of 3.0 cps declared, with a 55% payout of underlying NPAT and an 8.7% yield.
Outlook and guidance
Long-term ambitions target underlying NPAT above $200 million, NIM above 4%, CTI ratio below 35%, and ROE of 12-14% by FY2028.
NIM expected to expand above 4% in NZ and above 3.4% in Australia by Q3 FY25, with CTI ratio projected to rise short-term but targeted to fall below 35% by FY28.
No formal FY2025 NPAT guidance due to ongoing volatility; payout ratio for FY25 expected at least 50%.
Integration of Heartland Bank Australia and digitalisation initiatives expected to drive future growth.
Latest events from Heartland Group
- $620M merger forms NZ's seventh largest bank, targeting $34M synergies and EPS growth by 2026.HGH
M&A announcement24 Jun 2026 - Profit dropped on higher impairments, but reverse mortgage growth and NIM expansion continue.HGH
H1 202515 Jun 2026 - FY2025 underlying NPAT met guidance; FY2026 targets $85m+ NPAT and 7%+ ROE.HGH
H2 202515 Jun 2026 - NPAT surged to $48.8m, with NIM and asset quality gains, and FY2026 guidance reaffirmed.HGH
H1 202615 Jun 2026 - Impairment expenses surged amid rising arrears and defaults, with tough conditions expected to continue.HGH
Investor presentation14 May 2026 - FY2025 underlying NPAT set to exceed $45m, with strong growth and improved asset quality.HGH
Investor presentation14 May 2026 - Strategic reset, financial rebound, and digital focus drive growth and efficiency.HGH
AGM 202513 Nov 2025 - Lower profit but strong receivables growth and strategic transformation set the FY2028 path.HGH
AGM 202413 Jun 2025